wavePod

AI-powered podcast summaries delivered to your inbox within minutes of release.

Product

How It Works
Browse Podcasts
Your Library

Company

About Wave
Privacy Policy
Terms of Service

Get Wave AI

Download App
WaveTube — YouTube Summaries
Contact

© 2026 Wave. All rights reserved.

Back to The Uromigos

Episode 387: ASCO GU 2025 -Neoadjuvant Disitamab Vedotin + Toripalimab in HER2+ MIBC: updated efficacy and safety results - The Uromigos cover

Episode 387: ASCO GU 2025 -Neoadjuvant Disitamab Vedotin + Toripalimab in HER2+ MIBC: updated efficacy and safety results

Fri Feb 14 2025

Powered by Wave AI

Get AI-powered summaries and transcripts for any meeting, phone call, or podcast.

AI SummariesFull TranscriptsSpeaker Identification

Available on iOS, Android, Mac, and Windows

Get Wave AI →

Loading summary...

Want AI summaries for your own recordings? Try Wave AI free →

No transcript available.

Episode 387: ASCO GU 2025 -Neoadjuvant Disitamab Vedotin + Toripalimab in HER2+ MIBC: updated efficacy and safety results - The Uromigos | Wave AI Podcast Notes